Apexigen, Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | |
|---|---|---|---|
| Revenue | — | — | — |
| Operating income | −$32.7M | −$603,185 | −$1,832 |
| Net income | −$32.1M | −$484,062 | −$1,832 |
| Total assets | $22.9M | $58.3M | $97,252 |
| Total liabilities | $16.5M | $236,363 | $73,106 |
| Equity | $6.4M | $4,796 | $0 |
| EPS (diluted) | $-1.62 | $-1.60 | — |
| Shares out. | 7.4M | 1.7M | 1.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- —
- Net margin
- —
- Return on equity
- −502.9%
- Return on assets
- −140.3%
- Return on capital (ROCE)
- −511.7%
- Liabilities / assets
- 72.1%
- Debt / equity
- 2.58×
- Book value / share
- $0.86
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -33.07distress
- Accruals / assets
- −6.0%clean
- Piotroski F-Score
- 2/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 2 warning● 1 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 15, 2022
- NT 10-Qmissed a reporting deadline ↗May 16, 2022
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2022
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2021
- NT 10-Qmissed a reporting deadline ↗May 17, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsAug 23, 2023
- Shareholder voteAug 22, 2023
- Delisting / listing-standard noticeAug 18, 2023
- Other material eventAug 15, 2023
- Entered a material agreement · Regulation FD disclosureMay 24, 2023
- Delisting / listing-standard noticeApr 12, 2023
- Costs from exit or disposal · Director / officer change · Other material eventFeb 27, 2023
- Director / officer changeFeb 14, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GSep 5, 2023
- 4FORM 4 SUBMISSIONAug 25, 2023
- 4FORM 4 SUBMISSIONAug 25, 2023
- 4FORM 4 SUBMISSIONAug 25, 2023
- 4FORM 4 SUBMISSIONAug 25, 2023
- 4FORM 4 SUBMISSIONAug 25, 2023
- 4FORM 4 SUBMISSIONAug 25, 2023
- 4FORM 4 SUBMISSIONAug 25, 2023
- 4FORM 4 SUBMISSIONAug 25, 2023
- 4FORM 4 SUBMISSIONAug 25, 2023
- 4FORM 4 SUBMISSIONAug 25, 2023
- 4FORM 4 SUBMISSIONAug 25, 2023
- 4FORM 4 SUBMISSIONAug 25, 2023
- 3/AFORM 3/A SUBMISSIONAug 24, 2023
- S-8 POSAug 23, 2023